Supply Chain | May 02, 2026
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The company posted revenue of €1,267 million, up 6% on a constant currency basis
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Subscribe To Our Newsletter & Stay Updated
